omni
aaps
First 6-Month Implant to Treat Opioid Addiction
First 6-Month Implant to Treat Opioid Addiction
Titan Pharmaceuticals, Inc., and partner Braeburn Pharmaceuticals today announced that the Psychopharmacologic Drugs Advisory Committee (PDAC) of the FDA voted 12 to 5 in favor of approving Probuphine, the first long-acting, subdermal buprenorphine imp...
How the FDA Boosts the Costs of New Drugs
How the FDA Boosts the Costs of New Drugs
Many aspects of the GOP's newly proposed A Better Way healthcare plan would improve the health system. But "A Better Way" seems to mean "Much of the Same" when dealing with Food and Drug Administration regulation.
Modernizing the Pharmaceutical Manufacturing Base
Modernizing the Pharmaceutical Manufacturing Base
If we used a time machine to transport a pharmaceutical scientist from the 1960s into a current pharmaceutical production plant, it might be surprising to learn that he would already be familiar with most of the processes and production techniques bein...
Ibuprofen Patch Heralds Side Effect Free Drug Future
Ibuprofen Patch Heralds Side Effect Free Drug Future
An ibuprofen patch that delivers the painkiller directly through the skin to the site of pain, at a consistent dose for up to 24 hours, has been developed by U.K. researchers. University of Warwick research chemist Professor David Haddleton told Reuter...
Clinical Testing And Scale-Up of Affordable Hep C Drug
Clinical Testing And Scale-Up of Affordable Hep C Drug
The Drugs for Neglected Diseases initiative (DNDi) and the Egyptian drug manufacturer Pharco Pharmaceuticals have signed agreements covering the clinical testing and scale-up of a hepatitis C treatment regimen at a price of just under $300. If our ...